Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220004735 220010961 null 59.8 Curative (C) 2014-04-10 2014-04-10 Trial Unspecified Y N 220026688 TRIAL
220004736 220010961 0 null Palliative (P) 2017-06-01 2017-06-07 Cytarabine Low Dose N N 220026688 CYTARABINE
220004737 220010961 1.76 80.1 null 2013-01-23 2013-01-26 AML17 TRIAL 01 N 220026688 AML17 TRIAL
220004738 220010961 1.7 null Disease modification (D) 2013-08-10 2013-08-17 Cytarabine Low Dose 2 N 220026688 CYTARABINE
220004739 220010961 1.79 null Disease modification (D) 2017-10-26 2017-11-02 Cytarabine Low Dose N N 220026688 CYTARABINE
220004740 220021701 1.76 60 Disease modification (D) 2016-10-09 2016-10-10 Cytarabine Low Dose N N 220026696 CYTARABINE
220004741 220001877 null 59.4 Palliative (P) 2017-05-06 2017-05-12 CYTARABINE 2 null 220026697 CYTARABINE
220004742 220001878 1.82 42 Curative (C) 2016-01-16 2016-02-07 AML17 TRIAL 1 N 220026698 AML17 TRIAL
220004743 220001878 null 77.4 Curative (C) 2013-09-23 2013-09-23 Trial Unspecified 1 null 220026698 TRIAL
220004744 220015850 1.68 79 Curative (C) 2015-01-02 2015-01-02 LI-1 TRIAL Y N 220026700 TRIAL
220004745 220018688 1.52 62.4 Curative (C) 2017-07-12 2017-07-12 AML17 TRIAL 01 N 220026704 AML17 TRIAL
220004746 220018688 1.56 108.4 Curative (C) 2013-10-23 2013-10-31 Trial Unspecified 1 null 220026704 TRIAL
220004747 220001879 1.7 94 Disease modification (D) 2017-10-07 2017-10-12 Cytarabine low (10to20mg/m2) IV/SC 02 null 220026709 CYTARABINE
220004748 220001879 1.77 101 Palliative (P) 2014-07-29 2014-08-02 Cytarabine Low Dose 2 N 220026709 CYTARABINE
220004749 220001879 1.8 57.2 null 2015-03-26 2015-03-27 Trial Unspecified Y N 220026709 TRIAL
220004750 220001879 1.75 70.5 null 2013-05-06 2013-05-07 Trial Unspecified 01 N 220026709 TRIAL
220004751 220001879 1.6 80 Disease modification (D) 2013-10-22 2013-10-22 AML17 TRIAL 1 N 220026709 AML17 TRIAL
220004752 220001879 1.75 73.4 Palliative (P) 2013-12-29 2013-12-30 Cytarabine Low Dose 2 N 220026709 CYTARABINE
220004753 220001879 0 50.1 Curative (C) 2015-12-06 2015-12-18 AML17 TRIAL 2 N 220026709 AML17 TRIAL
220004754 220001879 1.71 88.3 Disease modification (D) 2017-06-29 2017-06-30 Cytarabine Low Dose 02 null 220026709 CYTARABINE
220004755 220001879 1.7 73.8 Curative (C) 2013-08-27 2013-08-28 AML17 TRIAL 01 N 220026709 AML17 TRIAL
220004756 220001880 null 95.3 Curative (C) 2017-10-30 2017-10-31 AML17 TRIAL Y N 220026721 AML17 TRIAL
220004757 220001880 1.84 77.3 Curative (C) 2017-03-27 2017-03-27 LI-1 TRIAL 1 N 220026721 TRIAL
220004758 220001880 1.5 87 Curative (C) 2017-11-23 2017-11-23 Trial Unspecified Y null 220026721 TRIAL
220004759 220001880 null 68 null 2015-11-17 2015-11-20 Cytarabine Low Dose Y N 220026721 CYTARABINE
220004760 220001881 1.8 77 Disease modification (D) 2017-12-29 2017-12-29 LI-1 TRIAL 1 N 220026733 TRIAL
220004761 220010965 1.8 82.1 Curative (C) 2015-11-17 2015-11-17 Trial Unspecified 1 N 220026734 TRIAL
220004762 220001882 null 0 Palliative (P) 2016-01-23 2016-01-23 Cytarabine Low Dose 02 N 220026739 CYTARABINE
220004763 220001882 null 7 Curative (C) 2015-08-03 2015-08-03 Cytarabine Low Dose N N 220026739 CYTARABINE
220004764 220001883 1.82 60.2 Curative (C) 2016-04-30 2016-05-06 AML17 TRIAL 99 null 220026743 AML17 TRIAL
220004765 220001883 null 106 Palliative (P) 2015-02-25 2015-02-25 CYTARABINE 02 N 220026743 CYTARABINE
220004766 220001883 1.83 93 Palliative (P) 2015-10-25 2015-10-25 Trial Unspecified 01 null 220026743 TRIAL
220004767 220001883 1.78 50.6 Curative (C) 2014-08-14 2014-08-15 AML17 TRIAL N N 220026743 AML17 TRIAL
220004768 220001884 1.75 64 Palliative (P) 2013-09-18 2013-09-24 Cytarabine Low Dose 02 N 220026747 CYTARABINE
220004769 220001884 null 0 Palliative (P) 2013-03-31 2013-04-11 CYTARABINE Y N 220026747 CYTARABINE
220004770 220015854 1.7 68.4 Palliative (P) 2014-08-06 2014-08-06 CYTARABINE 02 N 220026749 CYTARABINE
220004771 220015854 1.49 51.5 Curative (C) 2017-04-30 2017-05-03 Cytarabine Low Dose N N 220026749 CYTARABINE
220004772 220015854 1.82 81.4 null 2013-12-07 2013-12-12 AML17 TRIAL null N 220026749 AML17 TRIAL
220004773 220001885 0 null Palliative (P) null 2014-11-28 Cytarabine Low Dose N N 220026752 CYTARABINE
220004774 220010969 null 82.3 Curative (C) 2016-02-20 2016-02-20 AML17 TRIAL null null 220026753 AML17 TRIAL
220004775 220010969 1.76 91 Curative (C) 2013-11-20 2013-11-26 AML17 TRIAL Y N 220026753 AML17 TRIAL
220004776 220010969 null null Disease modification (D) 2015-08-14 2015-08-14 CYTARABINE N N 220026753 CYTARABINE
220004777 220001886 1.57 58.5 Curative (C) 2016-08-13 2016-08-14 Trial Unspecified N N 220026762 TRIAL
220004778 220001887 1.57 56.5 Curative (C) 2016-02-28 2016-02-28 AML17 TRIAL 1 null 220026763 AML17 TRIAL
220004779 220010970 null null Palliative (P) null 2014-01-12 Cytarabine Low Dose null null 220026764 CYTARABINE
220004795 220001889 1.78 90 Curative (C) 2017-08-07 2017-08-09 AML17 TRIAL Y N 220026797 AML17 TRIAL
220004796 220010972 null 57.3 null 2014-11-29 2014-11-30 CYTARABINE N N 220026800 CYTARABINE
220004797 220001890 1.85 55.4 Curative (C) 2016-02-06 2016-02-07 AML17 TRIAL 1 N 220026802 AML17 TRIAL
220004798 220001890 null null Palliative (P) null 2016-02-03 Cytarabine Low Dose null null 220026802 CYTARABINE
220004799 220001890 1.85 84.8 Curative (C) 2017-10-03 2017-10-03 Trial Unspecified Y N 220026802 TRIAL